Related Experiment Video
Updated: Mar 7, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
A Clinical Trial with "cotaryl Cream" in Hyperkeratotic Skin Conditions
Cotaryl cream, containing 12% urea, effectively treated hyperkeratotic skin conditions in a clinical trial. The study found 60% of patients experienced excellent to good results with minimal side effects.
Area of Science:
- Dermatology
- Clinical Pharmacology
Background:
- Hyperkeratotic skin conditions present a significant dermatological challenge.
- Urea-based formulations are recognized for their therapeutic properties in managing such conditions.
Purpose of the Study:
- To evaluate the efficacy and safety of Cotaryl cream in patients with hyperkeratotic skin conditions.
- To assess the therapeutic outcomes of a 12% urea cream in a clinical setting.
Main Methods:
- A clinical trial involving 60 patients with various hyperkeratotic skin conditions.
- Application of Cotaryl cream (12% urea) over a one-year period.
- Assessment of treatment outcomes based on predefined efficacy criteria.
Main Results:
- Excellent results were observed in 11 patients, and good results in 25 patients, totaling 60% with excellent to good outcomes.
- Moderate results were noted in 15 patients, and poor results in 7 patients.
- Adverse effects were minimal, with only two patients reporting mild erythema and burning sensation.
Conclusions:
- Cotaryl cream (12% urea) demonstrates significant efficacy in treating hyperkeratotic skin conditions.
- The formulation is well-tolerated, with a favorable safety profile for dermatological use.
More Related Videos
07:29Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells